Gilead’s drug Remdesivir showed preliminary positive results in clinical trials. But what is this drug and how, exactly, does it work?
Academic rigor, journalistic flair
Articles on Pandemic
Displaying 1321 - 1340 of 1571 articles
Economic lockdowns and border restrictions have caused cross-border movement to plunge. Could this be the beginning of a system that’s more resistant to global ecological disaster and pandemics?
Cuban medicine is now called upon both to protect the island’s population from Covid-19 and to help various foreign countries, including Italy and France.
In addition to the elderly and health workers, those holding front-line jobs are particularly exposed. Infection risk and aggravating co-morbidities could compound social inequalities in time of crisis.
Despite the best efforts of governments, schools and parents there’ll be learning losses across the board and worsened educational outcomes for the poor.
COVID-19 is having a significant impact on the health, economic and social status of slum dwellers.
COVID-19 and SARS are both deadly – but different. SARS symptoms were quick to appear, making it easier to contain. Because health officials were able to contain it, the virus died off.
The health benefits of exercise for our mind and body are well documented. But did you know that exercise could lower the risks of the most dangerous COVID-19 complication?
Ottawa used the old War Measures Act when it wanted sweeping powers to deal with extraordinary events. Prime Minister Justin Trudeau has mused about using the newer Emergencies Act during the pandemic.
As Nigeria battles COVID-19, systemic corruption and a low level of accountability in the health sector may undermine efforts to halt the devastating effect of the virus.
As most of the world early awaits a vaccine for COVID-19, a smaller group of people scoffs. They could spell real trouble in the effort to build widespread immunity.
There’s a disconnect between how many low-wage workers are being described, and what they’re experiencing on the ground.
The coronavirus pandemic is an exceptionally challenging time for start-ups. Here’s a guide to help new businesses survive.
Over 30 countries today are making people wear masks in public, despite serious doubts from scientists.
The federal government is trying to entice independent schools to open by offering them advance payments. But do they have powers beyond enticement with which they could control state schools?
As countries get ready to re-open their economies, will there be a post-pandemic recovery? History and current economic models suggest those looking for a quick rebound will be disappointed.
The danger of treating COVID-19 as an astronomically rare and improbable event is that we will treat it as such and fail to prepare for the next pandemic. And there will be another pandemic.
Bluetooth wireless communication makes it possible to track when people have been exposed to people infected with the coronavirus. The right cryptography scheme keeps alerts about exposures private.
In emergencies, time is a currency. If the government fails to deliver basic income to the people, the consequences could be catastrophic.
Countries aiming to flatten the coronavirus curve have one crucial aim: reduce the “effective reproduction number” of the virus to below 1. This means the spread is slowing, rather than accelerating.
Top contributors
-
Associate Professor, Epidemiology, Deakin University
-
Professor of Medicine, University of Virginia
-
Lecturer in Psychology, Swansea University
-
Joel Lexchin is a Friend of The Conversation.
Professor Emeritus of Health Policy and Management, York University, Canada
-
Associate Professor of Viral Immunology, Department of Pathobiology, University of Guelph
-
Professor of Global Biosecurity, NHMRC L3 Research Fellow, Head, Biosecurity Program, Kirby Institute, UNSW Sydney
-
Professor, Biology, York University, Canada
-
Professor of Epidemiology Healthcare Infection and Infectious Diseases Control, UNSW Sydney
-
Dean and Professor of Public Health, The Ohio State University
-
Research associate, Warren Alpert Medical School, Brown University, Brown University
-
Professor of Operations Management & Business Analytics, Carey Business School, Johns Hopkins University
-
Professor and Chair, Department of Journalism, Stellenbosch University
-
Chair in Epidemiology, Deakin University
-
Professor of Immunology and Associate Dean, Research and Graduate Studies, University of Guelph
-
Professor of Social Development Studies, University of Johannesburg
